A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
A study revealing new structural details of an intracellular channel that controls muscle contraction may lead to new drugs for heart and muscle diseases.
A lightning-fast camera paired with an electron microscope has enabled Columbia scientists to capture images of one of the smallest proteins in our cells.
People with moderate or severe pain have a 41 percent higher risk of developing prescription opioid use disorders, researchers at Columbia University Medical Center have found.
Intranasal flu vaccines may provide long-lasting protection against pandemic flu strains, according to a study from immunologists at Columbia University Medical Center.
Columbia University has received a $58.4 million grant from the NIH's National Center for Advancing Translational Sciences to expand its work in translational research.